<DOC>
	<DOCNO>NCT00286923</DOCNO>
	<brief_summary>The purpose study determine use non-invasive magnetic stimulation medication Topiramate adjust excitability migraine sufferer 's brain . Previous study show migraine sufferer 's brain excitable . The magnetic stimulation device give u way look excitability see change time headache diary show pattern severity headache change administration drug Topiramate . It expect migraine sufferer fewer headache topiramate test magnetic stimulation show brain less excitable topiramate change character headache pattern excitabilty would change baseline test medication start .</brief_summary>
	<brief_title>Does Topiramate Adjust Excitability Brain Migraine Sufferers ?</brief_title>
	<detailed_description>We propose clinic-based study test hypothesis topiramate modulates excitability occipital cortex migraine . Subjects 18 55 year old , migraine aura accord IHS criterion recruit headache clinic . All eligible subject occipital cortex stimulation use Magstim 200 apparatus . Magnetic brain stimulation perform use 95 mm round coil Magstim 200 stimulator . All subject provide ear plug prevent possible noise damage ear . The recording conduct semi-darkened room . Subjects asked focus center dark screen . A 95 mm diameter circular coil apply occipital scalp midline , 7 cm anterior inion . Stimulator intensity increase 10 % increment subject report see phosphenes ( bright scintillate scotoma subject visual field generate occipital cortical stimulation ) maximum 100 % intensity reach . generate occipital cortical stimulation ) maximum 100 % intensity reach . Stimulation intensity fine tune determine threshold phosphenes barely see . In subject report see phosphenes till 100 % intensity , stimulator move 1 cm step try define optimum point stimulation . No 20 stimulation give frequency shall keep less 5/min . The threshold phosphenes generate record . To assess inhibitory function occipital cortex visual suppression method utilized . Timed TMS impulses usually 10 % phosphene threshold suppression note deliver . Subjects ask report letter project fixed luminance screen . Visual suppression calculate base number error subject make use automate analysis . The study procedure repeat patient take topiramate gradually increase dos achieve stable dose one month . Patients place 25 mg night 1 week , increase 25 mg B.I.D . one week maintain 50 mg B.I.D . d. There placebo study . e. Topiramate use study .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Headache Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Subjects 18 55 year old migraine headache define International Headache Society ( IHS ) . Subjects must willing take topiramate migraine prophylaxis 1 . Subjects frequent tension headache 2 . Subjects illdefined head pain 3 . Unable wean headache prophylaxis . 4 . Requiring daily use centrallyacting medication . 5 . Pregnant , lactate woman adequate birth control measure . 6 . Subjects personal family history seizure type . 7 . History head injury brain surgery . 8 . Cardiac pacemaker implant electronic device . 9 . Subjects history headache history tensiontype headache recur &gt; 1/month relieve counter medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>migraine</keyword>
	<keyword>chronic headache</keyword>
	<keyword>hyperexcitability</keyword>
	<keyword>Magnetic stimulation</keyword>
</DOC>